Capitalizing a Cure : how finance controls the price and value of medicines / Victor Roy.

Format:

Book

Author/Creator:

Roy, Victor, author.

Language:

English

Subjects (All):

Gilead Sciences (Firm).

Drugs--Prices--United States.

Drugs.

Physical Description:

1 online resource

Edition:

1st ed.

Place of Publication:

Oakland, California : University of California Press, 2023.

Language Note:

In English.

Summary:

"Capitalizing a Cure takes us into the struggle over accessing a medical breakthrough to investigate the power of finance over business, biomedicine, and public health. When sofosbuvir-based medicines launched in 2013, they promised a cure for millions of patients worldwide with hepatitis C. But their sticker shock-the drug was dubbed "the $1,000-a-day pill"-intensified a global debate over the pricing of new medicines. Weaving extensive historical research with insights from political economy and science and technology studies, Victor Roy demystifies an oft-missed dynamic in this debate: the reach of financialized capitalism into how medicines are made, priced, and valued. His account travels between public and private labs, Wall Street and corporate boardrooms, public health meetings and health centers to trace the ways sofosbuvir-based medicines became financial assets dominated by strategies of speculation and extraction at the expense of access and care. Provocative and sobering, this book illuminates the harmful impact of allowing financial markets to supersede democracy and human health and points to the necessary work of building more equitable futures."-- Provided by publisher.

Contents:

Preface : pandemics, Wall Street, and the value playbook

Introduction : the politics of drug pricing and the value of a cure

Capitalizing science : public knowledge into pharmaceutical assets

Capitalizing drugs : shareholder power and the cannibalizing company

Capitalizing health : the struggle over value and treatment access

From financialization to public purpose for health

Conclusion : reckoning with pharmaceutical value in crisis times.

Notes:

This eBook is made available Open Access under a CC BY-NC-ND 4.0 license: https://creativecommons.org/licenses/by-nc-nd/4.0 https://www.degruyter.com/dg/page/open-access-policy

Description based on publisher supplied metadata and other sources.

ISBN:

9780520388727

OCLC:

1374540806

Access Restriction:

Unrestricted online access.